Imke Engelbrecht

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study”.

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

The Lancet(2022)10.1016/s0140-6736(22)00007-1

N/A

4.4DataRank · unranked

85 citations

Nigel Garrett, Ameena Goga, Lara Fairall, Tarylee Reddy, Nonhlanhla Yende-Zuma +76 more

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial

PLoS Medicine(2022)10.1371/journal.pmed.1004024

N/A

0.961DataRank · unranked

21 citations

Azwidihwi Takalani, Ishen Seocharan, Nonhlanhla Yende‐Zuma, Tarylee Reddy, Imke Engelbrecht +23 more

Allergic reactions to the Ad26.COV2.S vaccine in South Africa

Journal of Allergy and Clinical Immunology Global(2021)10.1016/j.jacig.2021.12.002

N/A

0.292DataRank · unranked

6 citations

Cascia Day, Simbarashe Takuva, Azwidihwi Takalani, Imke Engelbrecht, Nigel Garrett +8 more

Allergic reactions to the Ad26.COV2.S Vaccine in South Africa

(2024)10.22541/au.170668816.68864620/v1

N/A

0DataRank · unranked

0 citations

Cascia Day, Simbarashe Takuva, Azwidihwi Takalani, Imke Engelbrecht, Nigel Garrett +8 more